In this live Q&A we are joined by Consultant Pharmacist Gastroenterologist Anja St Clair Jones, and Lead Neonatal Pharmacist Christian Chadwick. Anja and Christian answer questions or concerns around the medications taken by those born with OA/TOF.
[Tip: You can use the links below to jump to the relevant section over on YouTube]
03:14 What are the long-term effects of Proton Pump Inhibitors (PPIs)?
15:55 What are the long-term effects of omeprazole?
22:36 Are PPI’s detrimental to the gut biome?
28:20 Apart from PPIs, what else can be given to manage reflux in babies?
33:52 What is the maximum amount of PPI a child can take?
39:10 How often should I get medication reviewed due to weight gain?
42:55 Can you take omeprazole and azithromycin daily for life?
45:47 What treatments are available to treat Eosinophilic Oesophagitis in an adult born with long gap OA?
51:04 How long should someone take Losec?
53:15 TOAST trial research project update
58:30 How much PPI is too much?
1:00:17 What are the latest, most effective PPI medications?
1:02:37 What are the signs of silent reflux?
Christian Chadwick
Christian is the Lead Pharmacist for Neonatal Care at the Royal Sussex County Hospital in Brighton, home to the largest and only surgical Neonatal Intensive Care Unit serving Kent, Surrey, and Sussex.
In addition to his hospital role, Christian serves as the Pharmacy Lead for Neonatal Care across the Kent, Surrey & Sussex region. He collaborates with pharmacists and multidisciplinary healthcare teams to optimise medicines use for newborns across 13 hospitals providing neonatal care in the area.
Christian is also an active member of the UK Neonatal and Paediatric Pharmacy Group, contributing to national advancements in neonatal care as part of its Neonatology Committee.
Anja St. Clair Jones
Anja qualified as a pharmacist in Switzerland in 1987 and has since practiced as a clinical pharmacist in the United Kingdom.
In 2011 Anja completed an MSc in Advance Pharmacy Practice at University College London whilst leading the surgical team at the Brighton and Sussex University Hospitals NHS Trust.
In 2012 as an independent prescriber she established drug monitoring clinics for immunosuppressants used in gastroenterology and supervises the biologics infusion clinic, optimising and managing these therapies for the local IBD population. She leads the pharmaceutical service to the multidisciplinary Sussex Operational Delivery Network (ODN) providing regional services for viral hepatitis and hepatology inpatient and outpatient care.
In 2016 she gained the title of Consultant Pharmacist Gastroenterology with the remit to promote pharmacy services in Gastroenterology and is a Fellow of the RPS.
Anja is a committee member of the Gastroenterology and Hepatology Interest Group of the United Kingdom Clinical Pharmacy Association (UKCPA) and is the 2021 recipient of the prestigious UKCPA Outstanding Achievement Award. Anja was also a member of the national IBD Standards Steering group actively promoting specialised pharmacy practice until 2022. National and international publications showcase pharmaceutical care in the gastroenterology field and encourage and inspire young pharmacists to strive for excellence in pharmacy practice.
Information correct at time of recording (March 2025). Click here to read our disclaimer.
